DCM
APYX icon

DAFNA Capital Management’s Apyx Medical APYX Stock Holding History

DAFNA Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100,000
Closed -$239K – 77
2015
Q1 		$239K Buy
+100,000
New +$333K 0.18% 60

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

DAFNA Capital Management's APYX Position: Q2 2015 in Review

DAFNA Capital Management sold out of Apyx Medical (APYX) in Q2 2015, closing a stake of 100,000 shares — an estimated $239K sold.

DAFNA Capital Management first reported a position in APYX in Q1 2015 and held it in 1 quarter. The position peaked at $239K in Q1 2015. 32 funds tracked by Wall St. Rank hold APYX as of Q2 2015.

  • DAFNA Capital Management reported no remaining Apyx Medical position as of Q2 2015 after selling out during the quarter.
  • DAFNA Capital Management sold 100,000 Apyx Medical shares in Q2 2015, an estimated $239K.
  • DAFNA Capital Management first reported a position in Apyx Medical in Q1 2015 and held it in 1 quarter.
  • DAFNA Capital Management's Apyx Medical position peaked at $239K in Q1 2015.
  • 32 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2015.

Based on DAFNA Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.